US Patent Issued to Five Prime Therapeutics, Bristol-Myers Squibb on Oct. 7 for "Antibodies binding to ILT4" (California, Massachusetts, New Jersey Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,136, issued on Oct. 7, was assigned to Five Prime Therapeutics Inc. (Thousand Oaks, Calif.) and Bristol-Myers Squibb Co. (Princeton, N.J.).

"Antibodies binding to ILT4" was invented by Xiao Min Schebye (San Carlos, Calif.), Diana Yuhui Chen (San Francisco), Andrew Rankin (Redwood City, Calif.), Xiaodi Deng (San Mateo, Calif.), Joseph Toth (Belmont, Mass.), Linda Liang (Mountain View, Calif.), Michelle Minhua Han (Piedmont, Calif.), Christine Bee (San Francisco), Hong-An Truong (San Francisco), Mark J. Selby (San Francisco), Nils Lonberg (Woodside, Calif.), Guodong Chen (East Brunswick, N.J.), Richard Y. Huang (Bridgewater, N.J.), Ekaterina G. Deyanova (Lawrenceville, N.J.) and Alan...